Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 14 | 2012 | 692 | 1.730 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 9 | 2012 | 54 | 1.360 |
Why?
|
| Virus Release | 5 | 2011 | 14 | 1.180 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 4 | 2011 | 35 | 1.090 |
Why?
|
| Host-Pathogen Interactions | 3 | 2012 | 241 | 0.450 |
Why?
|
| Antigens, CD | 2 | 2012 | 343 | 0.430 |
Why?
|
| HIV Infections | 3 | 2011 | 913 | 0.420 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2010 | 210 | 0.420 |
Why?
|
| Ubiquitin | 2 | 2010 | 97 | 0.410 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2012 | 20 | 0.400 |
Why?
|
| Virion | 3 | 2009 | 119 | 0.360 |
Why?
|
| Protein Structure, Tertiary | 10 | 2012 | 657 | 0.350 |
Why?
|
| Nucleocapsid | 1 | 2010 | 12 | 0.340 |
Why?
|
| Virus Replication | 5 | 2012 | 305 | 0.340 |
Why?
|
| Gene Products, gag | 3 | 2009 | 63 | 0.300 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2008 | 24 | 0.300 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2008 | 53 | 0.290 |
Why?
|
| CD4 Antigens | 1 | 2008 | 148 | 0.290 |
Why?
|
| Virus Internalization | 1 | 2008 | 81 | 0.290 |
Why?
|
| Mutation | 6 | 2012 | 2456 | 0.270 |
Why?
|
| Cell Line | 7 | 2012 | 1984 | 0.240 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2000 | 1 | 0.180 |
Why?
|
| Ligases | 1 | 2000 | 26 | 0.180 |
Why?
|
| Ebolavirus | 1 | 2000 | 37 | 0.170 |
Why?
|
| Protein Binding | 6 | 2012 | 1557 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 2 | 2009 | 87 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 2 | 2009 | 106 | 0.150 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 384 | 0.130 |
Why?
|
| GPI-Linked Proteins | 2 | 2012 | 39 | 0.120 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2011 | 17 | 0.110 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 2 | 2010 | 4 | 0.110 |
Why?
|
| Humans | 15 | 2012 | 59360 | 0.110 |
Why?
|
| Ubiquitination | 2 | 2010 | 106 | 0.100 |
Why?
|
| Protein Structure, Secondary | 5 | 2012 | 253 | 0.100 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2012 | 6 | 0.100 |
Why?
|
| Virus Assembly | 2 | 2009 | 53 | 0.100 |
Why?
|
| Endosomes | 2 | 2012 | 170 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 153 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2010 | 112 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 83 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 133 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2011 | 400 | 0.080 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2009 | 1 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2010 | 238 | 0.080 |
Why?
|
| Models, Molecular | 5 | 2012 | 1128 | 0.080 |
Why?
|
| Avian Proteins | 1 | 2008 | 7 | 0.080 |
Why?
|
| Receptors, Virus | 1 | 2008 | 67 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2010 | 486 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 1554 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 450 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 661 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2008 | 253 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2010 | 425 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 540 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1151 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 418 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 461 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2009 | 697 | 0.060 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2003 | 3 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 1952 | 0.050 |
Why?
|
| Dimerization | 3 | 2009 | 144 | 0.050 |
Why?
|
| Tropism | 1 | 2002 | 16 | 0.050 |
Why?
|
| Transfection | 2 | 2003 | 675 | 0.050 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2002 | 68 | 0.050 |
Why?
|
| Binding Sites | 3 | 2012 | 881 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2000 | 41 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2000 | 170 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 356 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 288 | 0.040 |
Why?
|
| Brachytherapy | 1 | 1990 | 38 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2012 | 587 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2002 | 313 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2000 | 526 | 0.040 |
Why?
|
| Circular Dichroism | 2 | 2010 | 107 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 248 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 689 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1990 | 135 | 0.040 |
Why?
|
| Proteins | 1 | 2002 | 730 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2009 | 763 | 0.030 |
Why?
|
| Female | 2 | 2012 | 30705 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 98 | 0.020 |
Why?
|
| Male | 1 | 2012 | 27739 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 100 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2011 | 125 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 399 | 0.020 |
Why?
|
| Scattering, Small Angle | 1 | 2010 | 14 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 85 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2012 | 332 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2009 | 62 | 0.020 |
Why?
|
| HIV | 1 | 1989 | 68 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 184 | 0.020 |
Why?
|
| Genes, gag | 1 | 2009 | 11 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 424 | 0.020 |
Why?
|
| Cats | 1 | 2009 | 81 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2008 | 35 | 0.020 |
Why?
|
| Unilamellar Liposomes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2008 | 50 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1988 | 147 | 0.020 |
Why?
|
| Calorimetry | 1 | 2008 | 40 | 0.020 |
Why?
|
| RNA, Viral | 1 | 1989 | 259 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 234 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1988 | 133 | 0.020 |
Why?
|
| Carcinoma | 1 | 1988 | 115 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 490 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 258 | 0.020 |
Why?
|
| Kidney | 1 | 2009 | 416 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1988 | 215 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 289 | 0.020 |
Why?
|
| Animals | 3 | 2010 | 19651 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1988 | 839 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 33 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 76 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2003 | 96 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 279 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 255 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 270 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 584 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 293 | 0.010 |
Why?
|
| Iridium Radioisotopes | 1 | 1990 | 2 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1990 | 81 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1990 | 65 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1990 | 452 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 844 | 0.010 |
Why?
|
| Survival Rate | 1 | 1990 | 802 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1988 | 26 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 450 | 0.000 |
Why?
|
| Complement System Proteins | 1 | 1988 | 114 | 0.000 |
Why?
|
| Epitopes | 1 | 1988 | 286 | 0.000 |
Why?
|
| Base Sequence | 1 | 1989 | 1302 | 0.000 |
Why?
|